OTCPK:GATA

Stock Analysis Report

Executive Summary

Groupe Athena Inc., a research and testing organization, provides technical and regulatory consulting for biotechnical products, pharmaceuticals, diagnostics, medical equipment, and devices.

Snowflake

Fundamentals

Mediocre balance sheet with weak fundamentals.

Share Price & News

How has Groupe Athena's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

-19.4%

GATA

5.8%

US Healthcare

1.8%

US Market


1 Year Return

-45.8%

GATA

-6.5%

US Healthcare

7.3%

US Market

Return vs Industry: GATA underperformed the US Healthcare industry which returned -6.5% over the past year.

Return vs Market: GATA underperformed the US Market which returned 7.3% over the past year.


Shareholder returns

GATAIndustryMarket
7 Day-19.4%5.8%1.8%
30 Day173.3%2.5%-0.7%
90 Day173.3%-1.8%0.06%
1 Year-45.8%-45.8%-5.0%-6.5%9.7%7.3%
3 Year-77.9%-77.9%33.9%28.6%46.3%36.9%
5 Year-89.7%-89.7%65.6%55.8%64.5%46.5%

Price Volatility Vs. Market

How volatile is Groupe Athena's share price compared to the market and industry in the last 5 years?


Simply Wall St News

1 year ago | Simply Wall St

Top NasdaqGS Undervalued Stock

1 year ago | Simply Wall St

Financially Strong And High Value Stocks

1 year ago | Simply Wall St

Financially Strong And High Value Stocks

Valuation

Is Groupe Athena undervalued compared to its fair value and its price relative to the market?


In this section, we usually try to help investors determine whether Groupe Athena is trading at an attractive price based on the cash flow it is expected to produce in the future. But as Groupe Athena has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.


Next Steps

  • Take a look at our analysis of GATA’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don’t know where to start, we recommend reading through Groupe Athena regulatory filings here.
  • Explore potentially undervalued companies in the Healthcare industry.

Future Growth

How is Groupe Athena forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

10.8%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Groupe Athena has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

  • Take a look at our analysis of GATA’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access Groupe Athena's filings and announcements here.
  • Explore growth companies in the Healthcare industry.

Past Performance

How has Groupe Athena performed over the past 5 years?

13.9%

Historical Healthcare annual earnings growth


In this section we usually display a company’s past earnings and revenues to help investors visualise the trend through time. We also gauge the company’s performance by benchmarking its returns and growth to its industry peers and the wider market. However, Groupe Athena has not provided sufficient past data to assess its track record.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have historical data.


Next Steps

Financial Health

How is Groupe Athena's financial position?


In this section we usually analyse Groupe Athena's finance health to determine how well-positioned it is against times of financial distress, in particular, its ability to manage its cash and debt levels. Groupe Athena has not provided adequate balance sheet data, its financial health cannot be properly assessed as it.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have financial information.


Next Steps

  • Take a look at our analysis of GATA’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • Investors tend to look at the financial health of a company this size in order to assess the sustainability of its current operations. While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website.
  • Financial health is measured at one point in time, so the latest financial report is the best representation of the company’s current financial status. Check when Groupe Athena's financial data was last updated here.
  • Explore more healthy companies in the Healthcare industry.

Dividend

What is Groupe Athena's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%1.5%markettop25%3.7%industryaverage1.6%forecastin3Yearsn/a

Current dividend yield vs market & industry


Stability and Growth of Payments

Notable Dividend: Unable to evaluate GATA's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate GATA's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.

Stable Dividend: Insufficient data to determine if GATA's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if GATA's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of GATA's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

What is the CEO of Groupe Athena's salary, the management and board of directors tenure and is there insider trading?


CEO

Dipika Purohit 0

0yrs

Tenure

0

Ms. Dipika Purohit serves as the Chairman, Chief Executive Officer and President of Groupe Athena, Inc. 


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Management Team

  • Dipika Purohit

    Chairman

    • Tenure: 0yrs

Board Members

  • Dipika Purohit

    Chairman

    • Tenure: 0yrs
  • Pooja Rajpurohit

    Director

    • Tenure: 0yrs
  • Prakash Iyer

    Director

    • Tenure: 0yrs
  • Kalpathy Parameswaran

    Director

    • Tenure: 0yrs
  • Chitra Saxena

    Director

    • Tenure: 6.1yrs

Company Information

Groupe Athena Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Groupe Athena Inc.
  • Ticker: GATA
  • Exchange: OTCPK
  • Founded: 2008
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: US$1.353m
  • Shares outstanding: 47.14m
  • Website: https://www.groupeathena.com

Location

  • Groupe Athena Inc.
  • 10/234 Dadisheth Agiary Lane
  • Kalbadevi
  • Mumbai
  • Maharashtra
  • 400002
  • India

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
GATAOTCPK (Pink Sheets LLC)YesCommon StockUSUSDApr 2010

Biography

Groupe Athena Inc., a research and testing organization, provides technical and regulatory consulting for biotechnical products, pharmaceuticals, diagnostics, medical equipment, and devices. The company se ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/10/18 00:16
End of Day Share Price2019/10/17 00:00
Earnings2015/06/30
Annual Earnings2015/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.